A clinical trial led by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, has concluded that a Chinese traditional medicine compound, Tongxinluo, reduced major adverse cardiac ...
Many lower forms of life on earth exhibit an extraordinary ability to regenerate tissue, limbs, and even organs—a skill that is lost among humans and other mammals. Now, a University of Pittsburgh researcher has used the ...
Nov 22, 2016
4
141
Heart attack patients prescribed antidepressants have lower one-year survival rates, according to research presented today at Acute Cardiovascular Care 2018, a European Society of Cardiology congress.1
Mar 4, 2018
0
82
Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI-46. According to research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting, when ...
Jun 15, 2022
0
5
Patients hospitalized after a heart attack who had blood potassium levels of between 3.5 and less than 4.5 mEq/L (milliEquivalents per liter) had a lower risk of death than patients with potassium levels that were higher ...
Jan 10, 2012
0
0
(HealthDay)—Sensitivities and negative predictive values (NPVs) are higher for the 2020 European Society of Cardiology (ESC) 0/1-hour and 0/2-hour algorithms than the 0/3-hour algorithm for high-sensitivity cardiac troponin ...
Nov 23, 2021
0
1
Elevated cardiac troponin, a diagnostic marker of damage to the heart, may occur even if a patient has not had a heart attack, according to a study published in JACC: Basic to Translational Science.
May 9, 2017
0
0
The sun's radiation could be a factor in seasonal patterns of a deadly type of heart attack, according to new research that tracked a "summer shift" in their occurrence across seven countries.
Apr 9, 2018
0
114
A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have ...
Aug 26, 2022
0
118
P2Y12 inhibitor monotherapy lowers the risk of ischemic events compared with aspirin alone in patients with coronary artery disease without increasing bleeding risk, according to late breaking research presented in a Hot ...
Aug 29, 2022
0
7
